Jack H. Dean, Director at Dipexium Pharmaceuticals, Inc. (DPRX), bought 3,000 shares at $9.00 ($27K) on 2014-05-21, disclosed to the SEC on 2014-05-22.
Open-market purchase of $27k DPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |